Patent Term Application for VYALEV (foscarbidopa and foslevodopa). Patent No. 9,446,059
🏛 Food and Drug Administration (FDA)FDA-2025-E-0162
Documents
1
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
NoticeJun 29, 2026
Determination of Regulatory Review Period for Purposes of Patent Extension; VYALEVOpen · 26 days left